Ribo Life Science Raises USD 40M in Series E1 Round for siRNA Drug Development
China-based Suzhou Ribo Life Science Co., Ltd reportedly raised USD 40 million in a Series...
Viral hepatitis
Guangdong Releases 2022 Non-Immunization Vaccine Catalog (7th Batch)
The Guangdong Provincial Center for Disease Control and Prevention and Guangdong Medicine Exchange jointly released...
Ascletis Pharma Presents ASC22 Phase IIb Results for Chronic Hepatitis B at ILC 2022
China-based Ascletis Pharma Inc. (HKG: 1672) presented the latest results of a Phase IIb clinical...
Cosunter Pharma’s HBV Surface Antigen Inhibitor GST-HG121 Approved for Phase I Trial
China-based Fujian Cosunter Pharmaceutical Co., Ltd (SHE: 300436) has announced receiving approval from the ethics...
Scotland Reports First Case of ASHep-UA in Children, WHO Issues Guidelines
Scotland recorded its first case of acute severe hepatitis of unknown etiology in children (ASHep-UA)...